对帕金森症急性勒沃多巴挑战测试的基于Kinect的客观评估:可行性研究
Ronghua Hong1,2, Zhuang Wu1,2, Kangwen Peng2
1Department of Neurology and Neurological Rehabilitation, Shanghai Disabled Persons' Federation Key Laboratory of Intelligent Rehabilitation Assistive Devices and Technologies, School of Medicine, Shanghai Yangzhi Rehabilitation Hospital (Shanghai Sunshine Rehabilitation Center), Tongji University, Shanghai, China.
概括
本研究客观地评估了使用深度摄像机动力数据的急性勒沃多巴挑战测试 (ALCT). 脚触动动力学特征在评估帕金森症患者的勒沃多巴反应方面表现出色.
科学领域:
- 神经学 神经学
- 生物医学工程 生物医学工程
- 运动障碍 运动障碍
背景情况:
- 急性勒沃多巴挑战测试 (ALCT) 对于诊断帕金森症至关重要,但具有局限性.
- 需要对ALCT进行客观评估,以克服现有的缺陷.
研究的目的:
- 使用深度摄像头客观地评估ALCT.
- 为了确定最佳的动力学指标来评估勒沃多巴的反应.
主要方法:
- 59名帕金森症患者接受了ALCT.
- 运动障碍学会赞助的统一帕金森病评分表第三部分 (MDS-UPDRS III) 修订的改善率被计算出来.
- 使用Azure Kinect深度摄像头记录了Levodopa关闭和启动状态期间的动态特征.
主要成果:
- 莱沃多巴反应 (IR) 与各种运动的动力特征 (起身,手/手指/脚,腿敏捷性,步态) 有显著的相关性.
- 选择的动力学特征显示了临床显著的勒沃多巴反应 (AUC 0.673-0.915) 中等到高的辨别能力.
- 使用脚触动动力学特征的分类器获得了优异的性能 (AUC 0.966),最佳切断值为21.24%.
结论:
- 该研究证实了使用基于Azure Kinect的系统进行客观ALCT评估的可行性.
- 动力学数据提供了一种可靠的方法来测量勒沃多巴在帕金森病的作用.
- 这种方法提高了ALCT的客观性和精度.
相关概念视频
01:24Parkinson's Disease: Treatment
273
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
273
01:15Parkinson's Disease: Overview
553
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
553